Mark Purcell Stock Analyst Profile - Morgan Stanley Research Coverage - Stocknear

Mark Purcell

Stock Analyst at Morgan Stanley

(3.35)
# 2784
Out of 5,506 analysts
6
Total ratings
Success rate
Average return
Main Sectors:

5 Stocks

Name Action PT Current % Upside Ratings Updated
SNY Sanofi
Upgrades: Overweight
56 58
50.9 13.95% 2 Sep 8, 2025
NVS Novartis
Initiates Coverage On: Equal-Weight
114
132.42 -13.91% 1 Jan 23, 2024
GSK GSK
Initiates Coverage On: Equal-Weight
44
43.34 1.52% 1 Jan 23, 2024
AZN AstraZeneca
Initiates Coverage On: Overweight
85
85.31 -0.36% 1 Jan 23, 2024
NVO Novo Nordisk
Initiates Coverage On: Overweight
120
59.64 101.21% 1 Jan 23, 2024